Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q1 2016 call → NOThe question asks whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket — with three conditions: (1) paying now for something not yet earning, (2) the wait is the company's main current work, (3) the far side is a specific, near-dated, already-visible event. Let me scan the transcript for any such description. Key topics discussed: - Q1 2016 results, sales growth, recruiting, etc. - Colonial Penn sales up 14%, EBIT loss of $7 million due to seasonal TV advertising — but that's ordinary operating expense for a business already earning. - DOL Fiduciary Rule — they're conducting a review, not paying for something. - Tennenbaum Capital Partners investment — strategic investment, but not described as a waiting period. - Bankers Life broker/dealer and registered investment advisor rollout — "national rollout of the Bankers Life broker/dealer and registered investment advisor later this quarter." This is mentioned as a priority. But is it described as a cost being borne now with a near-dated benefit? The transcript says "the national rollout of the Bankers Life broker/dealer and registered investment advisor later this quarter" — but there's no description of current costs being absorbed, no mention of the wait being the main work, no specific near-dated event with resources already committed. Let me look for anything about a waiting period, pre-operating costs, commissioning, ramping, etc. The transcript mentions: - "we have been expecting to fully utilize our life net operating loss carryforwards in 2016. We expect our life NOLs to be fully utilized in the second quarter and we will begin to pay cash taxes in the third quarter." — This is about starting to pay taxes, not a waiting period. - Colonial Penn EBIT loss due to advertising — ordinary. - No mention of a facility, site, line, vessel, store, clinic being carried before it operates. - No mention of inventory bought for volume not yet shipping. - No mention of a program being funded before it yields. The closest might be the broker/dealer rollout, but management doesn't describe it as a current cost with a near-dated benefit. It's just listed as a priority. There's no description of a self-funded interval before a specific arrival.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.